GNI Group Ltd. 13D and 13G filings for Gyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 5:11 pm Unchanged | 2024-01-22 | 13D | Gyre Therapeutics, Inc. GYRE | GNI Group Ltd. | 73,313,885 85.340% | 0 (Unchanged) | Filing |
| 2023-11-27 4:49 pm Unchanged | 2023-11-22 | 13D | Gyre Therapeutics, Inc. GYRE | GNI Group Ltd. | 73,313,885 85.360% | 0 (Unchanged) | Filing |
| 2023-11-01 4:58 pm Purchase | 2023-10-30 | 13D | Gyre Therapeutics, Inc. GYRE | GNI Group Ltd. | 73,313,885 85.360% | 73,313,885 (New Position) | Filing |